Elegen and GSK Sign Collaboration and Licensing Agreement to Further Develop Elegen’s Cell-Free DNA Production Technology

Contributed by: Business Wire

Logo

Business Wire logo

Tags

Science
Other Science
Biotechnology
Research
Pharmaceutical
Health
Genetics
Other Health
GSK

More Like This

PR Newswire associated0

EnGeneIC Selects Global CDMO BioCina to Advance Their Ground-Breaking Cancer Treatment

PR Newswire associated0

Seegene and Springer Nature Announce Strategic Alliance

Business Wire logo

Sangamo Therapeutics Announces Global Epigenetic Regulation and Capsid Delivery License Agreement with Genentech to Develop Novel Genomic Medicines for Neurodegenerative Diseases

PR Newswire associated0

Cytosurge and Lexogen Partner to Advance Live-Cell Sequencing

PR Newswire associated0

Solvias to Perform Release Testing on World's First CRISPR-based Gene-Editing Therapy

Jumpcode Genomics and Takara Bio USA Announce Global Patent Partnership

PR Newswire associated0

Seegene Announces Collaboration with Microsoft to Realize 'a World Free from All Diseases'

PR Newswire associated0

/C O R R E C T I O N -- Seegene Inc./